These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31784728)

  • 1. Neuronal impact of patient-specific aberrant NRXN1α splicing.
    Flaherty E; Zhu S; Barretto N; Cheng E; Deans PJM; Fernando MB; Schrode N; Francoeur N; Antoine A; Alganem K; Halpern M; Deikus G; Shah H; Fitzgerald M; Ladran I; Gochman P; Rapoport J; Tsankova NM; McCullumsmith R; Hoffman GE; Sebra R; Fang G; Brennand KJ
    Nat Genet; 2019 Dec; 51(12):1679-1690. PubMed ID: 31784728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRXN1α
    Avazzadeh S; Quinlan LR; Reilly J; McDonagh K; Jalali A; Wang Y; McInerney V; Krawczyk J; Ding Y; Fitzgerald J; O'Sullivan M; Forman EB; Lynch SA; Ennis S; Feerick N; Reilly R; Li W; Shen X; Yang G; Lu Y; Peeters H; Dockery P; O'Brien T; Shen S; Gallagher L
    BMC Neurosci; 2021 Sep; 22(1):56. PubMed ID: 34525970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Ca
    Avazzadeh S; McDonagh K; Reilly J; Wang Y; Boomkamp SD; McInerney V; Krawczyk J; Fitzgerald J; Feerick N; O'Sullivan M; Jalali A; Forman EB; Lynch SA; Ennis S; Cosemans N; Peeters H; Dockery P; O'Brien T; Quinlan LR; Gallagher L; Shen S
    Mol Autism; 2019; 10():52. PubMed ID: 31893021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia.
    Ishizuka K; Yoshida T; Kawabata T; Imai A; Mori H; Kimura H; Inada T; Okahisa Y; Egawa J; Usami M; Kushima I; Morikawa M; Okada T; Ikeda M; Branko A; Mori D; Someya T; Iwata N; Ozaki N
    J Neurodev Disord; 2020 Sep; 12(1):25. PubMed ID: 32942984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derived
    Pak C; Danko T; Mirabella VR; Wang J; Liu Y; Vangipuram M; Grieder S; Zhang X; Ward T; Huang YA; Jin K; Dexheimer P; Bardes E; Mitelpunkt A; Ma J; McLachlan M; Moore JC; Qu P; Purmann C; Dage JL; Swanson BJ; Urban AE; Aronow BJ; Pang ZP; Levinson DF; Wernig M; Südhof TC
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34035170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic contribution of Nrxn1α to autism-relevant behavioral phenotypes in mice.
    Xu B; Ho Y; Fasolino M; Medina J; O'Brien WT; Lamonica JM; Nugent E; Brodkin ES; Fuccillo MV; Bucan M; Zhou Z
    PLoS Genet; 2023 Feb; 19(2):e1010659. PubMed ID: 36848371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling Mechanisms of Patient-Specific NRXN1 Mutations in Neuropsychiatric Diseases Using Human Induced Pluripotent Stem Cells.
    De Los Angeles A; Tunbridge EM
    Stem Cells Dev; 2020 Sep; 29(17):1142-1144. PubMed ID: 32122280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine Restores Thalamic-Prefrontal Cortex Functional Connectivity in a Mouse Model of Neurodevelopmental Disorder-Associated 2p16.3 Deletion.
    B Hughes R; Whittingham-Dowd J; Simmons RE; Clapcote SJ; Broughton SJ; Dawson N
    Cereb Cortex; 2020 Apr; 30(4):2358-2371. PubMed ID: 31812984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation of four iPSC lines from a male ASD patient carrying a deletion in the middle coding region of NRXN1α gene (NUIGi039-A and NUIGi039-B) and a male sibling control (NUIGi040-A and NUIGi040-B).
    Ding Y; O'Brien A; Marcó de la Cruz B; Yang M; Lu Y; Qian X; Yang G; McInerney V; Krawczyk J; Lynch SA; Howard L; Allen NM; O'Brien T; Gallagher L; Shen S
    Stem Cell Res; 2021 May; 53():102254. PubMed ID: 33631419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation of iPSC lines from two patients with autism spectrum disorder carrying NRXN1α deletion (NUIGi041-A, NUIG041-B; NUIGi045-A) and one sibling control (NUIGi042-A, NUIGi042-B).
    Ding Y; O'Brien A; de la Cruz BM; Yang M; Fitzgerald J; Yang G; Li W; McInerney V; Krawczyk J; Lynch SA; Howard L; Allen NM; O'Brien T; Gallagher L; Shen S
    Stem Cell Res; 2021 Apr; 52():102222. PubMed ID: 33578364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia-associated NRXN1 deletions induce developmental-timing- and cell-type-specific vulnerabilities in human brain organoids.
    Sebastian R; Jin K; Pavon N; Bansal R; Potter A; Song Y; Babu J; Gabriel R; Sun Y; Aronow B; Pak C
    Nat Commun; 2023 Jun; 14(1):3770. PubMed ID: 37355690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous deletion of α-neurexin I or α-neurexin II results in behaviors relevant to autism and schizophrenia.
    Dachtler J; Ivorra JL; Rowland TE; Lever C; Rodgers RJ; Clapcote SJ
    Behav Neurosci; 2015 Dec; 129(6):765-76. PubMed ID: 26595880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-dependent novelty response in neurexin-1α mutant mice.
    Laarakker MC; Reinders NR; Bruining H; Ophoff RA; Kas MJ
    PLoS One; 2012; 7(2):e31503. PubMed ID: 22348092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAR-RPTPs Directly Interact with Neurexins to Coordinate Bidirectional Assembly of Molecular Machineries.
    Han KA; Kim YJ; Yoon TH; Kim H; Bae S; Um JW; Choi SY; Ko J
    J Neurosci; 2020 Oct; 40(44):8438-8462. PubMed ID: 33037075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation of familial iPSC lines from three ASD patients carrying NRXN1α
    Ding Y; Marcó de la Cruz B; Xia Y; Liu M; Lu Y; McInerney V; Krawczyk J; Lynch SA; Howard L; O'Brien T; Gallagher L; Shen S
    Stem Cell Res; 2019 Dec; 41():101653. PubMed ID: 31759289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single cell analysis of autism patient with bi-allelic NRXN1-alpha deletion reveals skewed fate choice in neural progenitors and impaired neuronal functionality.
    Lam M; Moslem M; Bryois J; Pronk RJ; Uhlin E; Ellström ID; Laan L; Olive J; Morse R; Rönnholm H; Louhivuori L; Korol SV; Dahl N; Uhlén P; Anderlid BM; Kele M; Sullivan PF; Falk A
    Exp Cell Res; 2019 Oct; 383(1):111469. PubMed ID: 31302032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous exonic and intragenic NRXN1 deletion presenting as either West syndrome or autism spectrum disorder in two siblings.
    Aksu Uzunhan T; Ayaz A
    Clin Neurol Neurosurg; 2022 Mar; 214():107141. PubMed ID: 35101781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing schizophrenia-related phenotypes in mice caused by autoantibodies against NRXN1α in schizophrenia.
    Shiwaku H; Katayama S; Gao M; Kondo K; Nakano Y; Motokawa Y; Toyoda S; Yoshida F; Hori H; Kubota T; Ishikawa K; Kunugi H; Ikegaya Y; Okazawa H; Takahashi H
    Brain Behav Immun; 2023 Jul; 111():32-45. PubMed ID: 37004758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered medial prefrontal cortex and dorsal raphé activity predict genotype and correlate with abnormal learning behavior in a mouse model of autism-associated 2p16.3 deletion.
    Hughes RB; Whittingham-Dowd J; Clapcote SJ; Broughton SJ; Dawson N
    Autism Res; 2022 Apr; 15(4):614-627. PubMed ID: 35142069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders.
    Hu Z; Xiao X; Zhang Z; Li M
    Mol Psychiatry; 2019 Oct; 24(10):1400-1414. PubMed ID: 31138894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.